Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: early outcomes with prior or concurrent sleeve gastrectomy
Loading...
Official URL
Full text at PDC
Publication date
2024
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
ELSEVIER SCIENCE
Citation
Gagner M, Almutlaq L, Cadiere GB, Torres AJ, Sanchez-Pernaute A, Buchwald JN, Abuladze D. Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: early outcomes with prior or concurrent sleeve gastrectomy. Surg Obes Relat Dis. 2024 Apr;20(4):341-352. doi: 10.1016/j.soard.2023.10.018. Epub 2023 Nov 10. PMID: 38114385.
Abstract
Background: Conventional metabolic/bariatric surgical anastomoses with sutures/staples may cause severe adverse events (AEs). Objectives: The study aim was to evaluate the feasibility, safety, and effectiveness of primary and revisional side -to -side duodeno-ileostomy (DI) bipartition using a novel magnetic compression anastomosis device (Magnet Anastomosis System [MS]). Setting: Multicenter: private practices and university hospitals. Methods: In patients with body mass index ([BMI, kg/m (2) ] >= 35.0 to < 50.0 with/without type 2 diabetes [T2D] glycosylated hemoglobin [HbA1C > 6.5 %]), two linear MS magnets were delivered endoscopically to the duodenum and ileum with laparoscopic assistance and aligned, initiating magnet fusion and gradual DI (MagDI). The MagDI- after -SG group had undergone prior sleeve gastrectomy (SG); the MagDI + SG group underwent concurrent SG. AEs were graded by Clavien-Dindo Classification (CDC). Results: Between November 22, 2021 and May 30, 2023, 43 patients (88.0% female, mean age 43.7 +/- 1.3 years) underwent the study procedures. The MS met feasibility criteria of magnet device placement, creation of patent anastomoses confirmed radiologically, and magnet passage in 100.0% of patients. There were 64 AEs, most were CDC grade I and II, significantly fewer in the MagDI-after-SG group ( P < .001). No device -related AEs including anastomotic leakage, bleeding, obstruction, infection, or death. The MagDI-after-SG group experienced 6 -month mean weight loss of 8.0 +/- 2.5 kg ( P < .01), 17.4 +/- 5.0% excess weight loss (EWL). The MagDI + SG group had significantly greater weight loss (34.2 +/- 1.6 kg, P < .001), 66.2 +/- 3.4% EWL. All patients with T2D improved. Conclusions: In early results of a multicenter study, the incisionless, sutureless Magnet System formed patent, complication -free anastomoses in side -to -side DI with prior or concurrent SG.













